Outpatient initiation of dofetilide: insights from the complexities of atrial fibrillation management during the COVID-19 lockdown

被引:0
作者
Daniel A. N. Mascarenhas
Praveen C. Mudumbi
Bharat K. Kantharia
机构
[1] Drexel University College of Medicine,
[2] Cardiovascular and Heart Rhythm Consultants,undefined
[3] Icahn School of Medicine at Mount Sinai,undefined
来源
Journal of Interventional Cardiac Electrophysiology | 2022年 / 63卷
关键词
Dofetilide; Atrial fibrillation; CIED; Remote monitoring; Antiarrhythmic drugs; SARS-CoV-2 corona virus; COVID-19 lockdown;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:21 / 28
页数:7
相关论文
共 196 条
[1]  
Køber L(2000)Camm AJ; Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial Lancet. 356 2052-2058
[2]  
Bloch Thomsen PE(1999)Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group N Engl J Med. 341 857-865
[3]  
Møller M(2000)Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study Circulation. 102 2385-2390
[4]  
Torp-Pedersen C(1998)Conversion of atrial fibrillaton and maintenance of sinus rhythm by dofetilide: the EMERALD (European and Australian multicenter evaluative research on atrial fibrillation dofetilide) study Circulation. 98 633-296
[5]  
Carlsen J(2001)Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (DIAMOND) substudy Circulation. 104 292-2104
[6]  
Sandøe E(2014)2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society Circulation. 130 2071-240
[7]  
Egstrup K(2012)Reuse of explanted permanent pacemakers donated by funeral homes Am J Cardiol. 109 238-e831
[8]  
Agner E(2020)Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association Circulation 141 e823-155A
[9]  
Videbaek J(2000)Mortality in patients with atrial fibrillation-1 year follow up of EMERALD (European and Australian multicenter evaluative research on atrial fibrillation dofetilide) J Am Coll Cardiol 35 154A-995
[10]  
Marchant B(2019)Safety of rapid switching from amiodarone to dofetilide in atrial fibrillation patients with an implantable cardioverter-defibrillator Heart Rhythm. 16 990-225